Xcorporeal, Inc. Announces Signing Agreement With Fresenius AG for the Sale of Substantially All of Its Assets
12/21/2009 9:05:32 AM
More...
|
Xcorporeal, Inc. Announces Signing Agreement for the Sale of Substantially All of Its Assets
12/21/2009 7:22:51 AM
More...
|
Xcorporeal, Inc. Reports That Its Common Stock is Now Trading on Pink Sheets under Symbol “XCRP” As a Result of Being Delisted from NYSE Amex
9/4/2009 8:31:07 AM
More...
|
Xcorporeal, Inc. Reports on Receiving a Notice from NYSE Amex LLC of Its Intent to Initiate Delisting Proceedings
8/27/2009 9:42:19 AM
More...
|
Xcorporeal, Inc. Reports on Failure to Meet Listing Standards of NYSE AMEX
5/22/2009 9:20:08 AM
More...
|
Xcorporeal, Inc. Announces Filing of Form 10-K and 2008 Operational Highlights
4/1/2009 11:26:52 AM
More...
|
Xcorporeal, Inc. Streamlines Operations; Company Terminated 73% of Staff
3/17/2009 7:31:44 AM
More...
|
Xcorporeal, Inc. Announces the XCR-6 Dialysis Platform for Self-Directed Kidney Hemodialysis
11/12/2008 10:51:59 AM
More...
|
Xcorporeal, Inc. to Present Posters on Friday, November 7th, at The American Society of Nephrology’s Renal Week 2008
11/7/2008 10:04:20 AM
More...
|
Xcorporeal, Inc. Appoints Kelly J. McCrann as Chairman and CEO
10/8/2008 7:44:56 AM
More...
|
|